2002-33: Acceptance of Awards
(Research/Sponsored Programs)

2002-24: Account Closeout
(Research/Sponsored Programs)

2002-35: Accounting Authority and Responsibility
(Research/Sponsored Programs)

2003-18: Accounting of Disclosures of Protected Health Information to Patients Upon Their Request (Privacy and Security of PHI)

• HCH1353: Requests for Accounting of Disclosures of Protected Health Information
• HCH1354: Accounting Log for Disclosures of Protected Health Information for 50 or More Research Subjects
• HCH1355: Protected Health Information Disclosure Tracking Log

2002-15: Accounting for Matching Gifts
(Research/Sponsored Programs)

2002-16: Accounting for Program Income
(Research/Sponsored Programs)

2002-31: Administration of Clinical Trials
(Research/Sponsored Programs)

2002-23: Administration of Sponsored Projects
(Research/Sponsored Programs)

Animal Use in Research, Teaching and Testing
(University-wide Policy)

2006-15: Applicable Credits/Sponsored Programs

2002-30: Approval of Proposals
(Research/Sponsored Programs)

2004-02: Authority of the Human Subjects Protection Program

2002-38: Budgets
(Research/Sponsored Programs)

2015-07: Clinical Record Documentation Requirements for Participants Participating in a Clinical Trial

2006-07: Clinical Research/Trials Budget Review

2010-01: Clinical Research Trials Facility Discount for Hospital-Based Outpatient Programs

2006-08: Clinical Research/Trials Patient Billing Compliance

ClinicalTrials.Gov
(University-wide Policy)

2007-06: Clinical Trials Under Contract – Administrative Requirements

2002-27: Compliance with Federal Subrecipient Standards of OMB Uniform Guidance
(Research/Sponsored Programs)

2006-11: Contract Negotiations for Initiation of Clinical Research and/or Clinical Trials Negotiated by Staff in the office of Clinical and Translational Research

2002-37: Cost Accounting Standards (CAS)
(Research/Sponsored Programs)

2002-14: Cost Sharing/Matching Requirements
(Research/Sponsored Programs)

2002-07: Cost Transfers and Payroll Reallocations
(Research/Sponsored Programs)

2003-29: Creation, Use and Disclosure of De-Identified Protected Health Information (Privacy and Security of Protected Health Information (PHI))

• Certification of De-Identification

2002-20: Delinquent Payment and/or Non-payment of Project Cost by Sponsors
(Research/Sponsored Programs)

2002-19: Direct Billing
(Research/Sponsored Programs)

2002-39: Direct Cost Expenditures
(Research/Sponsored Programs)

2017-01: Educational Requirements for Clinical Trial Billing Compliance

2002-08: Effort Reporting
(Research/Sponsored Programs)

• Effort Reporting Procedures

2012-01: Email Communication with Patients/Research Participants

• Secure Email Communication: A Short Guide for Patients

2006-09: Establishment of a Billing Employer Account Number (BEAN) and individual “Case Number” for Clinical Research/Trial Patients

2006-06: Evaluation of Clinical Research/Trial for Medicare Reimbursement

Export Control
(University-wide Policy)

2002-26: External Audits
(Research/Sponsored Programs)

2002-10: Facilities and Administrative Costs
(Research/Sponsored Programs)

2002-11: Facilities and Administrative (F & A) Cost Rate Proposal Preparation
(Research/Sponsored Programs)

2002-28: Financial Record Retention
(Research/Sponsored Programs)

2002-34: Financial Responsibility
(Research/Sponsored Programs)

2002-18: Funding Under Letter of Credit Agreements
(Research/Sponsored Programs)

2002-12: Governing Standards
(Research/Sponsored Programs)

2006-13: Health Insurance Coverage for Cancer Clinical Trials in Connecticut

Human Stem Cell Research Approval
(University-wide Policy; Updates UConn Health Policy 2006-17 of August 11, 2006)

Human Subjects Research
(University-wide Policy)

2006-01: Individual Financial Conflict of Interest in Research

• Guidance and Procedures

2009-03: Institutional Conflicts of Interest in Research

2009-05: Institutional Discounts for Investigator – Initiated Clinical Trials

Intellectual Property and Commercialization
(University-wide Policy)

2002-21: Interim and Final Financial Reports
(Research/Sponsored Programs)

2004-04: IRB Approval of Human Research Conducted by Subcontractors

2012-05: Legal Representative for Health Care Decisions

• Appendix: Health Care Decisions Flowchart

2003-30: Limited Data-Set Creation, Use and Disclosure (Privacy and Security of (PHI))

• Certification of Limited Data Set for Research

2006-12: Monitoring/Auditing Policy for the Research Billing Compliance Program for Clinical Research/Trials

2002-32: Negotiation of Awards
(Research/Sponsored Programs)

2002-13: Negotiation of Facilities and Administrative (F & A) Costs and Employee Benefit Rates
(Research/Sponsored Programs)

2011-05: Occupational Exposure to Bloodborne Pathogens – Evaluation and Treatment

2005-13: Occupational Health Surveillance Program for All Employees Who Are Involved with Laboratory Animal Work

2003-17C: Patient Right to Amend His/Her Medical/Dental/Research and/or Billing Record

• HCH1352: Request for Amendment of Health Information

2003-17B: Patient Right to Request Copies of His/Her Medical/Dental/Research and/or Billing Record

• HCH551: Authorization to Obtain and/or Disclose Health Information

2003-17A: Patient Right to View His/Her Medical/Dental/Research and/or Billing Record

• HCH1351: Request to View Record/Notification of Approval or Denial to View

2004-09: Pre-Award Accounts

Policy on Alleged Misconduct in Research
(University-wide Policy)

2002-06: Procurement of Goods and Services
(Research/Sponsored Programs)

2006-10: Reconciliation of Clinical Research Funds

2014-06: Retention, Storage, and Disposal/Destruction of Medical Records

2002-29: Revenue Recognition
(Research/Sponsored Programs)

2002-41: Review and Approval of Research Involving Animal Subjects

2002-42: Review and Approval of Research Involving Human Subjects

2008-05: Senior/Key Personnel and Committed Effort
(Research/Sponsored Programs)

2002-17: Sponsored Project Payments
(Research/Sponsored Programs)

2002-22: Sponsored Projects Closeout
(Research/Sponsored Programs)

2009-06: Stabilization of Charges for Clinical Research Trials

2007-03: Storage in L Building Corridors

2006-02: Suspension or Termination of IRB Approval Imposed by Administrative Officers
(Human Subjects Protection Office)

2010-04: Transfer of Research Equipment and/or Other Assets to Another Institution

2002-36: Types of Sponsored Programs
(Research/Sponsored Programs)

2002-05: Unallowable Costs/Administrative Costs
(Research/Sponsored Programs)

2002-09: University Service Centers/Recharge Centers
(Research/Sponsored Programs)

2003-28: Use and Disclosure of PHI for Research Purposes (Privacy and Security of PHI)

• Authorization to Use and Disclose Protected Health Information for Research Purposes
• Assurance for Use of Protected Health Information (PHI) as Preparatory to Research and/or on Decedents
• IRB Application for HIPAA Waiver of Authorization

2002-25: Write-off of Overdrafts and Disallowances
(Research/Sponsored Programs)

2004-05: Written Agreements for Sponsored/Funded Research Involving Human Subjects